These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1560191)

  • 1. Remission of Raynaud's phenomenon after L-thyroxine therapy in a patient with hypothyroidism.
    Lateiwish AM; Fehér J; Baraczka K; Rácz K; Kiss R; Gláz E
    J Endocrinol Invest; 1992 Jan; 15(1):49-51. PubMed ID: 1560191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon and thyroid deficiency.
    Shagan BP; Friedman SA
    Arch Intern Med; 1980 Jun; 140(6):832-3. PubMed ID: 7387277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon in hypothyroidism.
    Shagan BP; Friedman SA
    Angiology; 1976 Jan; 27(1):19-25. PubMed ID: 1053460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myxoedema and Raynaud's phenomenon.
    Nielsen SL; Parving HH; Hansen JE
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):32-4. PubMed ID: 7124291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral L-arginine can reverse digital necrosis in Raynaud's phenomenon.
    Rembold CM; Ayers CR
    Mol Cell Biochem; 2003 Feb; 244(1-2):139-41. PubMed ID: 12701823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothyroidism, Raynaud's phenomenon, and acute myocardial infarction in a young woman.
    Sipilä R; Viitasalo K; Heikkilä J
    Clin Cardiol; 1983 Jun; 6(6):304-6. PubMed ID: 6872374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary Treatment for Severe Secondary Raynaud's Phenomenon: A Case Report.
    Leng CB; Lin GJ; Cao H; Liu ZJ
    Chin Med Sci J; 2022 Dec; 37(4):353-358. PubMed ID: 36316060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A in the treatment of Raynaud's phenomenon.
    Habib SM; Brenninkmeijer EEA; Vermeer MH; de Vries-Bouwstra JK; Velthuis PJ
    Dermatol Ther; 2020 Nov; 33(6):e14182. PubMed ID: 32794364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validity of plethysmography and the digital temperature recovery test in the diagnosis of primary and occupational Raynaud's phenomenon].
    Laroche GP; Thériault G
    Clin Invest Med; 1987 Mar; 10(2):96-102. PubMed ID: 3581549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis and treatment of Raynaud's phenomenon.
    Porter JM; Snider RL; Bardana EJ; Rösch J; Eidemiller LR
    Surgery; 1975 Jan; 77(1):11-23. PubMed ID: 1078555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.
    Warkentin TE; Whitlock RP; Teoh KH
    Am J Hematol; 2004 Jan; 75(1):56-62. PubMed ID: 14695634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and image improvement of Raynaud's phenomenon after botulinum toxin type A treatment.
    Zhao H; Lian Y
    Australas J Dermatol; 2015 Aug; 56(3):202-5. PubMed ID: 25817568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isosorbide dinitrate ointment in Raynaud's disease.
    Diehm C; Müller-Bühl U; Mörl H
    Z Kardiol; 1983; 72 Suppl 3():185-7. PubMed ID: 6364591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM; Malamet R; Wise RA
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The therapy of Raynaud's phenomenon].
    Di Giacinto G
    Clin Ter; 1993 Feb; 142(2):161-74. PubMed ID: 8472530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syncope and Raynaud's disease.
    Guiloff RJ; Rajakulendran S; Angus-Leppan H
    Arch Neurol; 2012 May; 69(5):608-13. PubMed ID: 22248476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.